Understanding the Two Fundamentally Different Premium Models
Form Health and Calibrate represent two distinct philosophies about what "premium" GLP-1 care means — and understanding that distinction is essential for evaluating whether either platform is right for you.
Form Health's premium is clinical. The platform's distinguishing feature is a Care Team led by physicians certified by the American Board of Obesity Medicine (ABOM), working alongside registered dietitians and advanced practice providers. This specialized clinical credential matters most for patients with high-complexity medical situations: BMI above 40, multiple obesity-related comorbidities, histories of treatment-resistant obesity, or complex medication interactions that require expert management. Form Health is also one of the telehealth partners featured on Eli Lilly's LillyDirect platform.
Calibrate's premium is programmatic. Calibrate's approach is less about physician specialization and more about a comprehensive lifestyle transformation framework — a structured program covering nutrition, sleep, exercise, and emotional health alongside GLP-1 medication access. Both platforms are oriented around FDA-approved brand-name GLP-1 medications (Wegovy, Zepbound, and similar) rather than compounded alternatives — neither is built as a cash-pay compounded GLP-1 provider. The program/membership fee covers coaching, clinical oversight, and (for Calibrate) insurance navigation infrastructure; medication cost is billed separately and depends heavily on insurance coverage.
These are not just different tiers of the same service — they are solving different problems for different patient profiles. Getting them confused leads to paying for the wrong premium.
Form Health: Deep Dive
Form Health — Clinical Excellence Model
Form Health positions itself at the clinical quality end of the GLP-1 telehealth spectrum. Its Care Team is led by ABOM-certified obesity medicine physicians working alongside registered dietitians and advanced practice providers — a meaningful credential that reflects deep, dedicated expertise with GLP-1 pharmacology, metabolic complications of obesity, and complex dose management. Obesity medicine board certification requires passing a rigorous examination and demonstrates a level of specialized knowledge beyond general internal medicine or family practice.
Form Health prescribes only FDA-approved anti-obesity medications — Wegovy, Zepbound, Mounjaro, and similar products — not compounded alternatives. The platform charges a monthly membership fee covering the Care Team, coaching, and ongoing monitoring; medication and lab costs are billed separately and depend on your insurance coverage. Form Health is also one of the telehealth partners on Eli Lilly's LillyDirect platform, giving patients a documented pathway to Zepbound specifically.
The tradeoff is transparency and total cost for uninsured patients: independent reviews have noted that Form Health's full cost structure (membership plus medication plus labs) isn't always clearly disclosed upfront, and for patients without insurance covering GLP-1 medications, the all-in monthly cost can run well above flat-rate compounded alternatives.
✓ Strengths
- ABOM board-certified obesity medicine physicians
- Registered dietitians and APPs on the Care Team
- LillyDirect partner for Zepbound specifically
- Expert dose management and complex case handling
- Regular video visits, not just async intake
✗ Limitations
- FDA-approved medications only — no compounded option
- Membership fee + medication + labs billed separately
- Cost transparency has been flagged in independent reviews
- Not cost-effective without insurance covering GLP-1
- Distinct from "Sequence" — verify you have the right company
Calibrate: Deep Dive
Calibrate — Comprehensive Metabolic Reset Program
Calibrate operates on a fundamentally different model than most GLP-1 telehealth platforms. Where most providers are primarily in the medication access business — getting patients the right GLP-1 prescription at a sustainable price — Calibrate is in the behavioral transformation business, with GLP-1 as one component of a broader, structured metabolic reset program.
The four-pillar framework (food, sleep, exercise, emotional health) is genuinely comprehensive and addresses the behavioral dimensions of obesity that medication alone cannot resolve. Calibrate's philosophy — that long-term weight maintenance requires habit change, not just appetite suppression — is clinically sound. The STEP 4 trial demonstrated clearly that GLP-1 weight loss reverses rapidly when medication is stopped, underscoring the importance of behavioral infrastructure for maintenance.
Calibrate's model is built around brand-name GLP-1 through insurance — the company prescribes only FDA-approved medications, no compounded options. As of 2026, Calibrate's program fee runs approximately $199/month with a 3-month minimum commitment (down from a higher price point in prior years); medication and labs are billed separately through insurance. For insured patients who successfully receive prior authorization and apply a savings card, total cost can be competitive. For cash-pay patients or those without insurance covering GLP-1, Calibrate's model is significantly more expensive than compounded alternatives.
✓ Strengths
- Most comprehensive behavioral coaching in GLP-1 market
- 4-pillar approach addresses long-term maintenance
- Brand-name GLP-1 + savings card can be cost-effective for insured
- Dedicated insurance navigation team
- Structured program designed for sustainable habit formation
✗ Limitations
- 3-month minimum commitment
- Medication cost depends entirely on insurance approval
- Not designed for cash-pay compounded GLP-1 patients
- No compounded medication option available
- Coaching premium only valuable if you consistently engage with it
The Annual Cost Reality: What You Actually Pay
Form Health — Insured/Brand Pathway
Calibrate — Insured Brand-Name Pathway
★ Luma Health — Flat-Rate Compounded
Full Three-Way Comparison
| Factor | Form Health | Calibrate | Luma Health |
|---|---|---|---|
| Program/membership fee | Verify directly | ~$199/mo (3-mo min.) | $0 — medication cost is the only cost |
| Medication type | FDA-approved only (Wegovy/Zepbound/Mounjaro) | FDA-approved only (Wegovy/Zepbound) | Compounded sema + tirz |
| Insurance required | Effectively yes for cost-effectiveness | Yes — model depends on it | ✓ No |
| Clinical specialization | ✓ ABOM board-certified obesity medicine MDs | Metabolic health MDs | Wasef Health, PC (GLP-1 focused) |
| Behavioral coaching | RD + APP support | ✓ Structured 4-pillar (food, sleep, exercise, emotional) | Not included |
| Minimum commitment | Verify directly | 3-month minimum | ✓ None — cancel anytime |
| Compounded GLP-1 option | No | No | ✓ Yes — $197–$297/mo flat |
| Pharmacy verifiable | Brand retail pharmacy | Brand retail pharmacy | ✓ VialsRX, TX #35264 |
| Cost predictability | Insurance-dependent | High variance — insurance-dependent | ✓ Flat rate — no surprises |
| Best for | Complex cases needing obesity medicine specialist + insurance | Insured patients wanting brand GLP-1 + structured coaching | Most cash-pay patients who want the best value |
Who Actually Needs a Premium Provider?
Honest Assessment: When Premium Is Worth It vs. When It's Not
Premium IS Worth Considering For...
- BMI above 40 with multiple obesity-related comorbidities (T2D, sleep apnea, hypertension, dyslipidemia)
- History of treatment-resistant obesity or multiple failed weight loss attempts
- Previous bariatric surgery with complex metabolic context
- Complex medication interactions requiring expert management (Form Health specifically)
- Insured patients with good Wegovy/Zepbound coverage who want structured behavioral support (Calibrate specifically)
- Patients who will genuinely engage with comprehensive coaching and believe behavioral structure is essential to their success
Premium Is NOT Necessary For...
- BMI 27–40 with relatively straightforward medical history
- First-time GLP-1 patients without complex comorbidities
- Cash-pay patients without usable insurance coverage for brand-name GLP-1
- Self-directed patients who will not consistently use behavioral coaching programs
- Patients who need month-to-month flexibility and cannot commit to multi-month programs
- Patients whose primary need is reliable GLP-1 access at a price they can sustain for 12+ months — where Luma Health at $197/month flat is both clinically appropriate and financially sustainable
No insurance dependency.
Just $197/mo flat, predictable.
Compounded semaglutide $197/month flat. VialsRX pharmacy (TX Board #35264). No contracts. Wasef Health, PC clinical oversight.
Start With Luma Health →Frequently Asked Questions
No. Sequence (formally Weekend Health, Inc.) was an independent telehealth weight-management platform that was acquired by WeightWatchers in April 2023 and folded into what is now WeightWatchers Clinic. Form Health is a separate, independent obesity-medicine telehealth company that has never been affiliated with Sequence or WeightWatchers. If you're looking for what happened to Sequence specifically, see our WeightWatchers Clinic coverage. This article compares Form Health and Calibrate as two distinct premium GLP-1 programs.
They serve meaningfully different patient profiles. Form Health is better for patients with complex metabolic situations who specifically need the clinical depth of ABOM-certified obesity medicine specialists and have insurance that can make FDA-approved medication access affordable. Calibrate is better for insured patients who want brand-name GLP-1 through insurance coordination alongside a structured behavioral coaching program and who will commit to engaging with the coaching fully. For the majority of cash-pay GLP-1 patients with straightforward weight management needs, neither premium platform's specific advantages justify the additional cost over a specialized but moderately priced provider like Luma Health at $197/month flat.
No. Both Form Health and Calibrate prescribe only FDA-approved brand-name GLP-1 medications (Wegovy, Zepbound, Mounjaro, and similar products) — neither offers compounded semaglutide or tirzepatide as a cash-pay alternative. This is a meaningful difference from providers like Luma Health, which is built around compounded GLP-1 at a flat monthly rate. If a compounded, insurance-free option is your priority, a compounded-focused provider will be the better fit.
As of 2026, Calibrate's program fee is approximately $199 per month with a 3-month minimum commitment, a reduction from higher pricing in prior years. This fee covers coaching, clinical oversight, and insurance navigation. Medication and lab costs are billed separately through insurance: for patients who receive prior authorization for Wegovy or Zepbound and apply the manufacturer savings card, medication can cost as little as $25/month. For patients whose insurance denies coverage or doesn't cover weight management medications, the medication must be obtained elsewhere at retail prices, and Calibrate's model — built around brand-name medication — is significantly more expensive than compounded alternatives for cash-pay patients.
If your medical situation involves BMI above 40, multiple obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), a history of failed weight loss treatment, or complex medication interactions, the clinical depth of an obesity medicine specialist (Form Health) or a comprehensive metabolic coaching program (Calibrate) may genuinely improve your outcomes. For these patients, the premium is more likely to translate to better clinical management. For patients with a BMI of 27 to 40, relatively straightforward health history, and primarily needing effective GLP-1 medication management, a clinically focused platform like Luma Health provides appropriate clinical oversight at a more sustainable cost.
This is the most important question to ask Calibrate before enrolling. If your insurance prior authorization for Wegovy or Zepbound is denied, the program fee has already been paid but your medication is not covered. Calibrate's response to this scenario — whether they offer refunds, alternative medication pathways, or other accommodations — should be clarified in writing before you provide payment. The high variability of insurance outcomes for GLP-1 medications makes this a real risk. If your insurance coverage for weight management medications is uncertain, a cash-pay compounded provider with no upfront program fee and month-to-month flexibility is a more financially prudent starting point.
Luma Health is the right choice when cost predictability and treatment sustainability matter more than clinical subspecialty credentials or comprehensive behavioral coaching. At $197/month flat for semaglutide (or $297/month for tirzepatide), with no annual commitment, no program fee, and all consultations included, Luma Health offers GLP-1 care at a price most patients can sustain for the full 12+ months typically needed to see meaningful weight loss results. The clinical services through Wasef Health, PC and pharmacy through VialsRX (TX Board #35264) provide appropriate clinical oversight for the majority of GLP-1 patients.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed 33755728
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- American Board of Obesity Medicine. ABOM Certification. abom.org
- WW International, Inc. Completes Acquisition of Sequence. Press Release, April 10, 2023. SEC.gov
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information. FDA.gov — Wegovy PI
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov